Overview
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. The vaccine contains the purified cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain. The bacterial culture is inactivated in the medium with the capsular polysaccharides precipated from the solution.
Background
Typhoid Vi polysaccharide vaccine is a vaccine that is administered intramuscularly. It is an active immunization for the prevention of typhoid fever caused by S typhi and is approved for use in persons two years of age or older. The vaccine contains the purified cell surface Vi polysaccharide extracted from Salmonella enterica serovar Typhi, S typhi Ty2 strain. The bacterial culture is inactivated in the medium with the capsular polysaccharides precipated from the solution.
Indication
No indication information available.
Associated Conditions
- Typhoid Fever caused by S. typhi
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/10/08 | Phase 1 | Recruiting | |||
2023/02/27 | Phase 4 | Not yet recruiting | |||
2022/04/26 | Early Phase 1 | Completed | |||
2017/10/18 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| TYPHIM VI INJECTION 0.025 mg/0.5 ml | SIN08481P | INJECTION | 25 micrograms | 12/16/1995 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960015 | 生物制品 | 注射剂 | 7/19/2022 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960097 | 生物制品 | 注射剂(注射液) | 11/18/2020 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S20140007 | 生物制品 | 注射剂 | 6/12/2024 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960039 | 生物制品 | 注射剂(注射液) | 4/22/2020 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960026 | 生物制品 | 注射剂 | 10/13/2020 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960038 | 生物制品 | 注射剂(注射液) | 4/22/2020 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960025 | 生物制品 | 注射剂 | 7/31/2020 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960024 | 生物制品 | 注射剂 | 8/31/2020 | |
| Vi Polysaccharide Typhoid Vaccine | 国药准字S10960013 | 生物制品 | 注射剂(注射液) | 11/18/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||